جست‌وجوی استاد و پژوهشگر

• Immunology
• Lipid Metabolism
• Infectious Diseases
• +۳ مورد دیگر

Dijin Xu is an Associate Research Scientist in the Department of Microbial Pathogenesis at Yale School of Medicine, Yale University. His research focuses on lipid metabolism, immunology, and molecular mechanisms underlying metabolic disorders and host-pathogen interactions. He holds a PhD from Tsinghua University (2016). Education: PhD in Microbiology, Tsinghua University, 2016 Research Interests: Dr. Xu’s work spans immunology (e.g., B cell biology and somatic hypermutation), lipid metabolism (lipid droplet dynamics and adipose tissue homeostasis), and virology (antiviral defense mechanisms against SARS-CoV-2). His studies integrate cellular biology, molecular genetics, and biochemical approaches to understand disease processes. Publications Overview: His recent work explores mechanisms of lipid droplet regulation, metabolic disorder prevention, and immune system function. Notable contributions include studies on Rab GTPases in lipid storage and ELOF1’s role in antibody diversification. Labs & Affiliations: He is affiliated with the West Campus Integrative Science & Technology Center at Yale University, focusing on interdisciplinary research in cellular and molecular biology.

Elemir Simkoمشاهده پروفایل

استاد

• Honey bee health
• Agricultural sustainability
• Comparative pathology
• +۳ مورد دیگر

Dr. Elemir Simko is a Professor in the Department of Veterinary Pathology at the University of Saskatchewan, affiliated with Prairie Diagnostic Services. He holds a DVM from the University of Belgrade (Yugoslavia) and a DVSc from the University of Guelph, and is a Diplomate of the American College of Veterinary Pathologists. Since 1998, he has coordinated core anatomic pathology courses at both undergraduate and graduate levels. His research focuses on honey bee health, agricultural sustainability, comparative pathology, and innate immunity. Recent work includes studies on honey bee pathogen dynamics, pesticide impacts, and equine septic arthritis diagnostics using biomarkers. He collaborates extensively with researchers on investigative pathology and contributes to diagnostic services. Education: DVM (University of Belgrade), DVSc (University of Guelph), ACVP Diplomate Key Research Themes: Honey bee health, infectious disease pathogenesis, antimicrobial resistance, and diagnostic pathology Collaborations: Prairie Diagnostic Services, multiple veterinary and agricultural researchers Dr. Simko’s publications span veterinary pathology, honey bee health, and equine medicine. His recent articles highlight advancements in diagnostic techniques for septic arthritis in horses and interventions to mitigate honey bee colony threats. He has no listed awards but maintains active roles in teaching and applied research.

Sharon Peacockمشاهده پروفایل

استاد

• Antimicrobial Resistance
• Infectious Disease Epidemiology
• Microbial Genomics
• +۳ مورد دیگر

Professor Sharon Peacock is a leading academic in medical microbiology and public health at the University of Cambridge. She holds the position of Executive Director & Chair of the COVID-19 Genomics UK Consortium (COG-UK) since 2020. Previously, she served as Professor of Clinical Microbiology at the London School of Hygiene & Tropical Medicine and University College London (2015-2019), and at the University of Cambridge Department of Medicine (2009-2015). Her research focuses on bacterial pathogens, antimicrobial resistance, and genomic surveillance of infectious diseases. Education and professional roles include non-executive directorships at Cambridge University Hospitals NHS Foundation Trust and Public Health England (seconded roles). She has been recognized with significant honors including Commander of the British Empire (CBE), MRC Millennium Medal, and Unilever Colworth Prize. Her work bridges laboratory research and public health policy, particularly in genomic epidemiology of pathogens like SARS-CoV-2 and MRSA. Key contributions include defining transmission patterns of nosocomial pathogens through genomic studies, developing strategies for antimicrobial resistance, and leading international responses to infectious disease outbreaks. Her research integrates clinical microbiology with advanced genomic technologies to inform global health strategies.

• Proteomics
• Microbiology
• Genetic Engineering
• +۵ مورد دیگر

Dr. Kaveh Emami is a researcher at Newcastle University , specializing in proteomics, microbiology, and biotechnology. His work spans plant biotechnology, bacterial adhesion, and marine microbiology. Key research areas: Proteomics, Microbial Genetics, Plant Biochemistry, and Environmental Microbiology. Collaborated on studies involving rice mutants, barnacle adhesion, antibiotic discovery, and algal-bacterial interactions. His recent publications (2023–2009) focus on proteomic analysis, bacterial pathways, and applications in agricultural and marine biotechnology. No explicit scientific awards are documented in the provided data. Co-authored studies with Professor Angharad MR Gatehouse , Professor Tony Clare , and Professor Jeff Errington highlight his interdisciplinary collaborations.

• Food Microbiology
• Microbial Genomics
• Food Safety
• +۳ مورد دیگر

Ahmed Abdelhamid is an Assistant Professor in the Department of Food Science and Human Nutrition at Michigan State University since August 2024. Previously, he served as a Senior Research Associate and Postdoctoral Researcher at The Ohio State University (2018-2024), and was a Principal Research Investigator and Lecturer at Benha University, Egypt (2016-2018). PhD (2015) : Joint supervision in Microbiology, University of Guelph & Benha University MSc (2011) & BSc (2008) : Microbiology, Benha University His research spans three interconnected domains: Microbial Omics for food safety (metagenomic analysis of food microbiomes), Pathogen Adaptation (Salmonella virulence dynamics), and Biofilm Reprogramming (metabolomics-driven antibiofilm strategies). Recent work explores stress responses in foodborne pathogens and omics-based approaches to microbiome engineering. Scientific contributions include key publications in Frontiers , Applied and Environmental Microbiology , and Antibiotics . Recognized for his joint supervision scholarship during doctoral studies, his research integrates food safety, microbial physiology, and metabolomics innovation.

• Malaria Research
• Infectious Diseases
• Antibiotic Resistance
• +۵ مورد دیگر

Martina Wade is a Researcher in the Department of Epidemiology of Microbial Diseases at Yale School of Public Health. Her work focuses on infectious diseases, particularly malaria and antibiotic resistance, with a global health perspective emphasizing sub-Saharan Africa. She collaborates on projects in Cameroon, Uganda, and Burkina Faso, addressing drug resistance mechanisms, diagnostic innovations, and public health interventions. Her research spans clinical trials (e.g., ivermectin mass drug administration protocols), microbiota analysis in livestock and human populations, and environmental transmission dynamics of pathogens. She has published extensively on malaria treatment efficacy, microbiome disruptions from antibiotic use, and novel diagnostic technologies like photoacoustic detection. Her work bridges laboratory science with field epidemiology, aiming to improve clinical outcomes and public health strategies. Key collaborations include Sunil Parikh, Justin Goodwin, and Fangyong Li, focusing on antimalarial resistance tracking and pediatric infection dynamics. Her laboratory is located at 60 College Street, Ste Room 711, New Haven, CT. Contact: martina.wade@yale.edu.

• Venom Research
• Toxinology
• Biomedical Research
• +۳ مورد دیگر

Dr. Holger Scheib is an Honorary Associate Professor in the School of the Environment at The University of Queensland. His research focuses on venom evolution, toxinology, and biomedical applications, particularly in reptiles, cnidarians, and other venomous organisms. He collaborates extensively with international researchers on projects involving venom structure-function relationships, evolutionary biology, and clinical implications of venom variation. Research interests span venom evolution, toxin structure and function, and their applications in biomedical contexts. He investigates venom diversity across species, including reptiles, sea anemones, and cnidarians, focusing on how these toxins interact with biological systems. His work also explores the intersection of venom components with allergens and their structural similarities, contributing to a deeper understanding of venom’s ecological and medical significance. His recent publications highlight advancements in understanding venom evolution, toxin structures, and clinical implications. Studies include comparisons of venom proteins with allergens, analyses of venom variation in rattlesnakes, and investigations into the molecular mechanisms of bacterial secretion systems. These works contribute to both basic biological research and potential applications in medicine and biodiscovery. No scientific awards or grants are explicitly mentioned in the provided text. Dr. Scheib’s research is primarily conducted through collaborations within the School of the Environment and international academic networks. No specific lab or team affiliations are detailed.

• Gut Microbiome
• Clostridioides difficile Infection (CDI)
• Fecal Microbiota Transplantation
• +۳ مورد دیگر

Anna Seekatz is an Assistant Professor in the Department of Biological Sciences at Clemson University, affiliated with the College of Science. Her research focuses on the gut microbiome, particularly its role in health and disease, with emphasis on Clostridioides difficile infection (CDI) and fecal microbiota transplantation (FMT). She received her PhD from the University of Maryland School of Medicine and completed postdoctoral training at the University of Michigan. Education : PhD, Molecular Microbiology and Immunology, University of Maryland School of Medicine, 2013 BS, Cellular and Molecular Biology, Western Washington University, 2006 Research Interests : Dr. Seekatz studies microbial interactions within the gut microbiota, including CDI pathogenesis and FMT mechanisms. Her lab investigates how microbial communities contribute to disease resistance and recovery, with a focus on identifying key species and metabolites involved in CDI clearance. Current projects include characterizing commensal Clostridia and their functional dependencies in the gut environment. Techniques employed include bioinformatics, animal models, and traditional microbiology. Lab & Advising : Her research group includes PhD students Sophie Millard, Clara Flores, Christine Woelfel-Monsivais, and postdoctoral fellow Disha Bhattacharjee. She teaches Pathogenic Bacteriology and a creative inquiry course on commensal Clostridia characterization. Lab Locations : Life Sciences Building 157A (Office), 160F and 172 (Labs).

Claire O'Brienمشاهده پروفایل

دانشیار

• Inflammatory Bowel Disease
• Gut Microbiome
• Host-Microbe Interactions
• +۳ مورد دیگر

Claire O'Brien is an Associate Professor in Biomedical Science (Virology) at the University of Canberra, leading the Host-Microbe Interactions research group. Previously, she held positions at the Australian National University (ANU) Medical School as a Lecturer and Senior Lecturer at the University of Wollongong. She earned her PhD from ANU in 2012, focusing on microbiological aspects of Crohn's disease. Her research investigates gut microbiome dysbiosis in diseases like inflammatory bowel disease (IBD), using in vitro co-cultures of bacteria and macrophages. Key projects include studying antimicrobial resistance in retail meat and microbial resilience in IBD patients. Dr. O'Brien has received prestigious awards, including the Australian Academy of Science France-Australia Fellowship and NHMRC Peter Doherty Biomedical Research Fellowship. Her work spans translational research, such as the 'GUTSY' project addressing sarcopenia in Crohn’s disease, and collaborations on microbiome dynamics. She actively supervises Honours and higher-degree research students in IBD and microbiome-related fields. Research interests include host-microbe interactions, Crohn's disease pathogenesis, and the role of the microbiome in health. Her lab employs genomic, transcriptomic, and microbiological techniques to uncover mechanisms linking microbial imbalances to disease. She is also engaged in public health initiatives, such as optimizing preconception care and reducing pregnancy complications in women with polycystic ovary syndrome (PCOS).

• Bacteriology
• Microbial Pathogenesis
• Inflammation
• +۴ مورد دیگر

Dr. John Rohde is an Associate Professor in the Department of Microbiology & Immunology at Dalhousie University's Faculty of Medicine. His research focuses on understanding mechanisms of bacterial pathogenesis, particularly how Shigella spp. exploits host cell systems. He holds a PhD in Biochemistry from the University of British Columbia and completed postdoctoral training at Duke University, Institut Pasteur, and Mount Sinai Hospital's Samuel Lunenfeld Research Institute. His lab develops genetic tools to study bacterial virulence at systems levels. Education: BS/MS in Bacteriology (University of Idaho), PhD in Biochemistry (UBC) Research Interests: Shigella pathogenesis, ubiquitin ligases, type III secretion systems Recent work includes studies on Shigella's manipulation of host actin via RACK1 and the role of ubiquitin in pathogen survival. He collaborates internationally on projects combining proteomics and immunology to uncover antimicrobial defense mechanisms.

Derrick Crookمشاهده پروفایل

استاد

• Medical Microbiology
• Antimicrobial Resistance (AMR)
• Genomics
• +۳ مورد دیگر

Professor Derrick Crook is a leading academic in medical microbiology at the Nuffield Department of Medicine , University of Oxford, while also serving as an Infectious Diseases Physician at Oxford University Hospitals NHS Trust. He combines clinical practice with cutting-edge research on pathogen genomics and antimicrobial resistance. Education : Medicine (University of Witwatersrand); Diploma of Tropical Medicine (London); Internal Medicine Specialization (University of Virginia); Infectious Diseases Fellowship (Tufts New England Medical Center) His research focuses on translating whole pathogen sequencing into clinical practice, studying Mycobacterium tuberculosis , Escherichia coli , and Clostridium difficile . Key projects include the CRyPTIC program (20-country tuberculosis resistance analysis) and development of AI-powered rapid diagnostics. Recent publications demonstrate his team's leadership in using genomic data to predict drug resistance and analyze disease trends through electronic health records . The research emphasizes practical applications for infection control and antibiotic stewardship. Scientific Contributions : NIHR Health Protection Research Unit Global Pathogen Analysis System (GPAS) Mykrobe Predictor software development As co-director of Oxford Biomedical Research Infection Theme, he leads a multidisciplinary team working to modernize infection diagnostics and treatment approaches.

Steven Sinkinsمشاهده پروفایل

استاد

• Mosquito-borne diseases
• Arbovirus control
• Wolbachia symbiosis
• +۴ مورد دیگر

Steven Sinkins is Professor in Microbiology and Tropical Medicine at the University of Glasgow, affiliated with the MRC-University of Glasgow Centre for Virus Research. His research focuses on controlling mosquito-borne diseases through innovative biological approaches. He directs the ANTI-VeC international research network and leads a team investigating microbial solutions to vector-borne pathogens. Research interests center on: Wolbachia symbionts for arbovirus control Microsporidian malaria-blocking symbionts in Anopheles mosquitoes Field implementation of biocontrol strategies against dengue and Zika viruses Molecular mechanisms of pathogen blocking in mosquito vectors Publication analysis reveals consistent focus on: Wolbachia-mediated viral inhibition mechanisms Field trials of novel vector control methods Genetic and symbiotic approaches to disease prevention Mosquito-symbiont-pathogen tripartite interactions Scientific recognition includes: Wellcome Trust Senior Research Fellowship (2006-2021) Leads multiple research grants: Wellcome Trust: Optimal implementation of Wolbachia programmes (2022-2027) Open Philanthropy: Microsporidia symbionts for malaria control (2020-2023) BBSRC: Genetic and symbiotic disease control strategies (2017-2020) Directs the Sinkins Group at the MRC-University of Glasgow Centre for Virus Research, collaborating internationally with partners in Malaysia, Kenya, Burkina Faso, and Australia to develop and implement novel vector control solutions.

• Autism Spectrum Disorder
• Biostatistical Methods
• Chronic disease
• +۴ مورد دیگر

Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.

Jodi Lindsayمشاهده پروفایل

استاد

• Microbial Pathogenesis
• Antimicrobial Resistance
• Bacterial Evolution
• +۵ مورد دیگر

Professor Jodi Lindsay is a Professor of Microbial Pathogenesis at City St George's, University of London and serves as the Director of Cross Cutting Research Themes at the Infection and Immunity Research Institute. She is also Deputy to the Deputy Vice Chancellor (Research & Enterprise) and Academic Lead for REF2021. Dr. Lindsay earned her PhD from the University of Western Australia, followed by post-doctoral positions at New York University Medical Center and the University of Sheffield. She joined St George's in 1998, receiving tenure in 2005 and achieving full professorship in 2012. Her research focuses on: Evolution of bacterial populations and horizontal gene transfer Antimicrobial resistance (AMR) mechanisms in pathogens Staphylococcus aureus and MRSA epidemiology and evolution Bacteriophage transduction and restriction modification systems Genomic analysis of bacterial pathogenicity She leads a research team investigating AMR gene acquisition and stability through approaches including experimental evolution, mathematical modeling, and whole-genome sequencing. Key discoveries include Staphylococcus aureus pathogenicity islands (SaPI), lineage-specific restriction-modification systems, and AMR transmission dynamics. Current research funding includes support from MRC and JPI-AMR, with previous major grants from Wellcome Trust, EU FP7, BBSRC, and DEFRA. Her research team includes Jake Wildfire, Alastair Clements, Max Wallat, and Amelia Williams-Walker. She collaborates internationally with institutions including London School of Hygiene & Tropical Medicine, Imperial College London, Royal Veterinary College, and Erasmus Medical Centre. Dr. Lindsay teaches and supervises students in MRes Biomedical Science, BSc programs, and PhD candidates including MRC-LID students.

Katherine Elizabeth Chettaمشاهده پروفایل

استادیار

• Neonatology
• Preterm Infant Nutrition
• Necrotizing Enterocolitis
• +۳ مورد دیگر

Katherine Elizabeth Chetta, M.D., serves as an Assistant Professor of Pediatrics in the College of Medicine at the Medical University of South Carolina (MUSC), practicing neonatology at Shawn Jenkins Children's Hospital in Charleston. Her clinical focus centers on critically ill newborns in the Neonatal Intensive Care Unit (NICU), with specialized expertise in preterm infant care and nutritional management. Dr. Chetta completed her educational journey with a B.S. in Chemistry (Honors) from the University of Kansas (2005), followed by her M.D. from Baylor College of Medicine (2009) where she earned Alpha Omega Alpha (AOA) distinction and High Honors. She completed Pediatrics Residency (2013) and Neonatology Fellowship (2016) at Baylor College of Medicine and the University of Texas Health & Science Center in Houston. Her research program investigates critical aspects of neonatal nutrition, particularly the biochemical properties of human milk and its role in preventing gastrointestinal disorders. Key focus areas include necrotizing enterocolitis (NEC) pathogenesis, free fatty acid metabolism in preterm milk, maternal vitamin D impacts on infant immunity, and quality improvement initiatives for human milk utilization. Collaborations span the Digestive Disease Research Center Core and Darby Children's Research Institute at MUSC, integrating laboratory science with clinical epidemiology. Analysis of her 15 most recent publications reveals dominant research trajectories: (1) Human milk composition and storage effects on infant outcomes, (2) NEC risk stratification through clinical/laboratory markers and imaging, (3) Social determinants of growth in preterm infants, and (4) Microbiome interactions with milk components. Her work bridges basic science (in vitro cytotoxicity studies) with clinical implementation (NICU quality improvement). Scientific recognition includes: Induction into Alpha Omega Alpha (AOA) Honor Medical Society Dr. Chetta actively collaborates with multidisciplinary teams across MUSC's research infrastructure, though specific grant details aren't provided in source materials. Her mentorship extends to medical trainees within the neonatology division, focusing on translational research methodologies. Current projects emphasize standardizing NEC diagnostic protocols and optimizing human milk feeding systems for vulnerable infants. She contributes to laboratory-based investigations at the Darby Children's Research Institute, particularly studying HAMLET complexes in human milk and their effects on intestinal cell metabolism. Her clinical work directly informs ongoing quality improvement initiatives aimed at increasing mother's own milk usage rates in the NICU.